Management

CEO

Mag.Thomas Pfeifer, PhD

Thomas Pfeifer, who holds a doctorate in biochemistry, focused on basic research in the course of his master’s and doctoral thesis. In the course of this he was awarded the Scandinavian "Young Investigator Award" and he was able to publish his research results in several international publications. At that time he was already working on pharmaceutical products and researching possible active substances that could potentially reduce the cholesterol absorption in the blood and also the enterogenic biosynthesis of cholesterol. After 4 years of successful basic research, Mr. Thomas Pfeifer decided to end his university career and switch to the pharmaceutical industry. During this time he was able to gain experience in various areas of pharmaceutical production (vaccine production, classic pharmaceutical products and sterile production). The professional breadth that Mr. Thomas Pfeifer has gained over the years covers the entire spectrum of pharmaceutical analysis. After completing the university course in pharmaceutical quality management in Vienna, he was also registered with AGES as a qualified person in accordance with AMBO 2009 and Article 49 of Directive 2001/83/EC.

mail: thomas.pfeifer@apislabor.at

phone: +43 (0)463 20 35 00 - 10

Education

Karl Franzens Universität Graz
Biochemie und Molekularbiologie, 2007

Medizinische Universität Graz
PhD Program Molecular Medicine, 2010

Career

Head Analytical Quality Control at Novartis

Head Quality Control at Merck KgaA

Supervisor BSL3 Laboratory at Baxter AG

Systemadministrator and Project Assistant at Sandoz

Schooling

Lean Management, Management courses, qualified person (QP), Radiation Protection Officer.

CEO

Mag. Herwig Tiefenbacher, MSc

After school, Herwig Tiefenbacher turned to the natural sciences with a commercial focus and completed his studies in functional plant physiology, bioindication and environmental monitoring at the Karl Franzens University in Graz. Core topics and focal points during his studies were basic research into physiological processes in higher plants, as well as basic research into secondary plant substances. As part of his diploma thesis, he researched the stress-physiological behavior of non-resistant Nicotiana tabacum (tobacco), infected with tobacco mosaic virus when treated with spagyric-homeopathically prepared Azadirachta indica (neem). Parallel to his university education, Mr. Tiefenbacher was able to gain professional experience in a pharmaceutical manufacturer, Spagyrik Pharma-Production GmbH. He completed his postgraduate master's degree in pharmaceutical quality management at the University of Vienna, which he completed with a master's thesis on the implementation of a new monograph in the German Homeopathic Pharmacopoeia. He was able to gain further experience in the pharmaceutical industry at Merck KGaA Spittal. As a qualified person, he headed the release office with a focus on the market release of medicinal products and dietary supplements. In addition to end product controls, quality assurance issues such as deviation or complaint management were also processed within the release office. After restructuring within the Quality Operations department, Mr. Herwig Tiefenbacher expanded his area of responsibility by taking over the Quality Assurance department.

mail: herwig.tiefenbacher@apislabor.at

phone: +43 (0)463 20 35 00 - 20